Effects of exercise on circulating tumor cells among patients with resected stage I-III colon cancer

被引:27
|
作者
Brown, Justin C. [1 ]
Rhim, Andrew D. [2 ]
Manning, Sara L. [3 ]
Brennan, Luke [3 ]
Mansour, Alexandra I. [3 ]
Rustgi, Anil K. [4 ]
Damjanov, Nevena [4 ]
Troxel, Andrea B. [5 ]
Rickels, Michael R. [4 ]
Ky, Bonnie [4 ]
Zemel, Babette S. [4 ,6 ]
Courneya, Kerry S. [7 ]
Schmitz, Kathryn H. [8 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Michigan, Med Sch, Ann Arbor, MI 48109 USA
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] NYU, New York, NY USA
[6] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[7] Univ Alberta, Edmonton, AB, Canada
[8] Penn State Coll Med, Hershey, PA USA
来源
PLOS ONE | 2018年 / 13卷 / 10期
基金
美国国家卫生研究院;
关键词
SURROGATE END-POINTS; COLORECTAL-CANCER; PHYSICAL-ACTIVITY; INSULIN-RESISTANCE; GROWTH-FACTOR; SHEAR-STRESS; BLOOD-FLOW; MORTALITY; SURVIVORS; OBESITY;
D O I
10.1371/journal.pone.0204875
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Physical activity is associated with a lower risk of disease recurrence among colon cancer patients. Circulating tumor cells (CTC) are prognostic of disease recurrence among stage I-III colon cancer patients. The pathways through which physical activity may alter disease outcomes are unknown, but may be mediated by changes in CTCs. Methods Participants included 23 stage I-III colon cancer patients randomized into one of three groups: usual-care control, 150 min-wk-1 of aerobic exercise (low-dose), and 300 min-wk-1 of aerobic exercise (high-dose) for six months. CTCs from venous blood were quantified in a blinded fashion using an established microfluidic antibody-mediated capture device. Poisson regression models estimated the logarithmic counts of CTCs. Results At baseline, 78% (18/23) of patients had >= 1 CTC. At baseline, older age (-0.12+/- 0.06; P=0.04), lymphovascular invasion (0.63+/-0.25; P=0.012), moderate/poor histology (1.09 +/-0.34; P=0.001), body mass index (0.07+/-0.02; P=0.001), visceral adipose tissue (0.08 +/-0.04; P=0.036), insulin (0.06+/-0.02; P=0.011), sICAM-1 (0.04+/-0.02; P=0.037), and sVCAM-1 (0.06+/-0.03; P=0.045) were associated with CTCs. Over six months, significant decreases in CTCs were observed in the low-dose (-1.34+/-0.34; P<0.001) and high-dose (-1.18+/-0.40; P=0.004) exercise groups, whereas no significant change was observed in the control group (-0.59+/-0.56; P=0.292). Over six months, reductions in body mass index (-0.07+/-0.02; P=0.007), insulin (-0.08+/-0.03; P=0.014), and sICAM-1 (-0.07+/-0.03; P=0.005) were associated with reductions in CTCs. The main limitations of this proof-of-concept study are the small sample size, heterogenous population, and per-protocol statistical analysis. Conclusion Exercise may reduce CTCs among stage I-III colon cancer patients. Changes in host factors correlated with changes in CTCs. Exercise may have a direct effect on CTCs and indirect effects through alterations in host factors. This hypothesis-generating observation derived from a small pilot study warrants further investigation and replication.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Incidence and survival among young women with stage I-III breast cancer
    Thomas, A.
    Rhoads, A.
    Pinkerton, E.
    Schroeder, M. C.
    Oelson, J. J.
    McNally, L. R.
    Hundley, W. G.
    Conway, K.
    Lynch, C. F.
    Romitti, P. A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [42] Higher circulating tryptophan metabolites are associated with improved survival among patients with stage I-III colorectal cancer: results from the FOCUS consortium
    Damerell, Victoria
    Brezina, Stefanie
    Ose, Jennifer
    Geijsen, Anne Jmr
    Ulvik, Arve
    Van Roekel, Eline H.
    Holowatyj, Andreana N.
    Kok, Dieuwertje E.
    van Duijnhoven, Franzel J. B.
    Li, Christopher I.
    Habermann, Nina
    Ulrich, Alexis B.
    Kampman, Ellen
    Weijenberg, Matty P.
    Gsur, Andrea
    Ueland, Per M.
    Schneider, Martin
    Ulrich, Cornelia M.
    Gigic, Biljana
    CANCER RESEARCH, 2023, 83 (07)
  • [43] Circulating tryptophan-kynurenine pathway metabolites are associated with all-cause mortality among patients with stage I-III colorectal cancer
    Damerell, Victoria
    Klaassen-Dekker, Niels
    Brezina, Stefanie
    Ose, Jennifer
    Ulvik, Arve
    van Roekel, Eline H.
    Holowatyj, Andreana N.
    Baierl, Andreas
    Bohm, Jurgen
    Bours, Martijn J. L.
    Brenner, Hermann
    de Wilt, Johannes H. W.
    Grady, William M.
    Habermann, Nina
    Hoffmeister, Michael
    Keski-Rahkonen, Pekka
    Lin, Tengda
    Schirmacher, Peter
    Schrotz-King, Petra
    Ulrich, Alexis B.
    van Duijnhoven, Franzel J. B.
    Warby, Christy A.
    Shibata, David
    Toriola, Adetunji T.
    Figueiredo, Jane C.
    Siegel, Erin M.
    Li, Christopher I.
    Gsur, Andrea
    Kampman, Ellen
    Schneider, Martin
    Ueland, Per M.
    Weijenberg, Matty P.
    Ulrich, Cornelia M.
    Kok, Dieuwertje E.
    Gigic, Biljana
    INTERNATIONAL JOURNAL OF CANCER, 2024,
  • [44] Kinetics of postoperative circulating cell-free DNA and impact on minimal residual disease detection rates in patients with resected stage I-III colorectal cancer.
    Cohen, Stacey A.
    Kasi, Pashtoon Murtaza
    Aushev, Vasily N.
    Hanna, Diana L.
    Botta, Gregory P.
    Sharif, Saima
    Laliotis, Georgios I.
    Sharma, Vivek R.
    Alqahtani, Ali
    Chandana, Sreenivasa R.
    Kang, Sandra
    Chakrabarti, Sakti
    Somer, Bradley G.
    Kasi, Anup
    Dayyani, Farshid
    Malla, Midhun
    Jurdi, Adham A.
    Liu, Minetta C.
    Aleshin, Alexey
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 5 - 5
  • [45] Racial disparities in the receipt of adjuvant chemotherapy in patients with resected stage I-III pancreatic adenocarcinoma.
    Sanford, Nina Niu
    Xu, Xiaohan
    Sher, David J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [46] Importance of Tumor Deposits in Patients with Stage III Colon Cancer
    Schrempf, M.
    Anthuber, Matthias
    CHIRURG, 2020, 91 (09): : 781 - 781
  • [47] Assessment of postoperative circulating tumour DNA to predict early recurrence in patients with stage I-III right-sided colon cancer: prospective observational study
    Lygre, Kristin B.
    Forthun, Rakel B.
    Hoysaeter, Trude
    Hjelle, Sigrun M.
    Eide, Geir E.
    Gjertsen, Bjorn T.
    Pfeffer, Frank
    Hovland, Randi
    BJS OPEN, 2024, 8 (01):
  • [48] Tumor cancer stem cell genetic profile as predictor of relapse in stage II and III radically resected colon cancer patients
    Giampieri, Riccardo
    Scartozzi, Mario
    Loretelli, Cristian
    Mandolesi, Alessandra
    Bittoni, Alessandro
    Faloppi, Luca
    Bianconi, Maristella
    Bearzi, Italo
    Cascinu, Stefano
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [49] Outcomes of 556 consecutive patients with stage I-III colon cancer managed in a single center over 10 years
    Xenophontos, Eleni
    Konstantinou, Ifigenia
    Kountourakis, Panteleimon
    Vassiliou, Vassilios
    Polyviou, Petros
    Vogazianos, Paris
    Papamichael, Demetris
    ANNALS OF GASTROENTEROLOGY, 2021, 34 (03): : 399 - 403
  • [50] Circulating tumor cells and circulating tumor DNA in colon cancer
    Fedyanin, Mikhail
    Polyanskaya, Elizaveta
    Tjulandin, Sergei
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2016, 9 (02) : 88 - 92